BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma & Biopharma Manufacturing

Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW014

Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic dis...

October 10, 2022 | News

Cytiva strengthens cell line development with CEVEC acquisition

Viral vector manufacturing and cell line development are keystone technologies in the making of gene therapies 46 scientific experts based in Cologne, G...

October 06, 2022 | News

Univercells Technologies Completes EUR 2M Expansion of the Nivelles, Belgium Site

Nivelles site expansion activities began in December 2020 when the company doubled its overall footprint. The initial focus was on expanding warehouse stor...

October 06, 2022 | News

Emerging Southeast pharma nations predicted to grow faster than Singapore

Pharma manufacturing growth in Thailand and Indonesia will see regional emerge as major exporting hub The pharma industry in Southeast Asia has scor...

October 06, 2022 | News

Pall Corporation Launches Three New Allegro™ Connect Systems

Pall Corporation extends its bioprocessing solution portfolio with the launch of three new Allegro Connect Systems. In conjunction with Pall’s Allegr...

September 28, 2022 | News

Lunit Showcases AI Solutions for Radiology at AOCR & KCR 2022

Lunit's demonstration focuses on how radiologists and AI solutions can create synergy through combined workflows Visitors invited to Lunit Demo Station ...

September 22, 2022 | News

SCG Cell Therapy To Establish Cell Therapy Pilot cGMP Manufacturing Facility And R&D Centre In Singapore

With the support of the Singapore Economic Development Board (EDB), the hub comprises a pilot manufacturing facility and an R&D centre. SCG expect...

September 21, 2022 | News

WuXi Biologics' Drug Substance and Drug Product Facilities Again Approved by U.S. FDA and EMA

After passing online Pre-Approval Inspection (PAI), WuXi Biologics received EMA GMP certificates for the commercial manufacturing of two biologics develope...

September 20, 2022 | News

Sanyou ,KangaBio to accelerate antibody drug development and innovation

KangaBio, as a rising star biotechnology company, is committed to developing innovative prodrugs and providing innovative medicine to address unmet clinica...

August 29, 2022 | News

Resilience Becomes Biomanufacturing Resource Partner for California Institute for Regenerative Medicine

National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, was named b...

August 24, 2022 | News

WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility

First announced in June 2021, this site will be WuXi STA's second facility in the United States, offering expanded capacity and greater flexibili...

August 17, 2022 | News

Everest Medicines Enters into Agreement with Gilead Sciences for Trodelvy in Asia Territories

Broadens development and access to Trodelvy for patients in Greater China and certain Asia Pacific Markets Strengthens balance sheet and streaml...

August 16, 2022 | News

WuXi ATU Announces Licensing Agreement with Janssen for TESSA™ Technology

WuXi ATU will license to Janssen its TESSA™ technology, a high-performance system that can produce 10 times more adeno-associated viral (AAV) vectors...

August 12, 2022 | News

Polyplus Introduces Transgene Plasmid Engineering Services for Optimized Viral Vector Manufacturing

Following the early 2022 acquisition of e-Zyvec, integration activities have focused on providing a deeper level of solutions support to customers. Using t...

August 03, 2022 | News

Stay Connected